Should I buy or sell Applied DNA Sciences stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks .

What is Applied DNA Sciences' stock price target for 2024?

1 Wall Street analysts have issued twelve-month price objectives for Applied DNA Sciences' shares. Their APDN share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next year. This suggests a possible upside of 334.8% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts .

How have APDN shares performed in 2024?

Applied DNA Sciences' stock was trading at $0.6168 at the beginning of 2024. Since then, APDN stock has decreased by 44.1% and is now trading at $0.3450. View the best growth stocks for 2024 here .

When is Applied DNA Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our APDN earnings forecast .

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its earnings results on Thursday, February, 8th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.31) by $0.22. The technology company had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 159.93% and a negative net margin of 80.14%.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com . James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO) , Advanced Micro Devices (AMD) , Ekso Bionics (EKSO) , Micron Technology (MU) , Arbutus Biopharma (ABUS) , VBI Vaccines (VBIV) , Gilead Sciences (GILD) , Vaxart (VXRT) , Sorrento Therapeutics (SRNE) and Intel (INTC) .

How do I buy shares of Applied DNA Sciences?

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free APDN Stock Alerts

$0.34

+0.01 (+2.99%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.33
▼
$0.38
50-Day Range: $0.33
▼
$0.68
52-Week Range: $0.31
▼
$1.86

Volume: 130,199 shs
Average Volume: 109,063 shs
Market Capitalization: $5.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.50

Get Applied DNA Sciences alerts:

Applied DNA Sciences MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 334.8% Upside
$1.50 Price Target
Short Interest: Healthy
1.59% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.63) to ($0.48) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.73 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Applied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Applied DNA Sciences has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.59% of the outstanding shares of Applied DNA Sciences have been sold short.
Short Interest Ratio / Days to Cover
Applied DNA Sciences has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Applied DNA Sciences has recently increased by 3.68%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Applied DNA Sciences does not currently pay a dividend.
Dividend Growth
Applied DNA Sciences does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for APDN.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Applied DNA Sciences this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
MarketBeat Follows
7 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.25% of the stock of Applied DNA Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 22.22% of the stock of Applied DNA Sciences is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Applied DNA Sciences are expected to grow in the coming year, from ($0.63) to ($0.48) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Applied DNA Sciences is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Applied DNA Sciences is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Applied DNA Sciences has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Applied DNA Sciences Stock (NASDAQ:APDN)

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

APDN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

APDN Stock News Headlines

April 9, 2024 | marketbeat.com

The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover

Marketbeat's many investor tools include analysts' rankings and sentiment trackers. These tools help investors and traders gauge market sentiment, showing trends and changes, updated revisions, and new reports.

April 9, 2024 | marketbeat.com

The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover (APDN)

Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 13, 2024 | americanbankingnews.com

Applied DNA Sciences (NASDAQ:APDN) Research Coverage Started at StockNews.com

March 14, 2024 | finanznachrichten.de

Applied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress

March 12, 2024 | msn.com

Applied DNA Sciences files to sell 11.29M shares of common stock for holders

February 24, 2024 | msn.com

Applied DNA Sciences (APDN) Price Target Increased by 12.50% to 2.30

February 23, 2024 | benzinga.com

Applied DNA Sciences Stock (NASDAQ:APDN) Earnings Dates and Earning Calls

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 22, 2024 | wsj.com

Applied DNA Sciences Inc.

February 22, 2024 | benzinga.com

Applied DNA Sciences Stock (NASDAQ:APDN) Dividends: History, Yield and Dates

February 10, 2024 | finance.yahoo.com

Applied DNA Sciences First Quarter 2024 Earnings: Beats Expectations

February 10, 2024 | insidermonkey.com

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call Transcript

February 9, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN) and Viking Therapeutics (VKTX)

February 9, 2024 | finance.yahoo.com

Q1 2024 Applied DNA Sciences Inc Earnings Call

February 8, 2024 | finanznachrichten.de

Applied DNA Sciences, Inc.: Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results

February 8, 2024 | benzinga.com

Recap: Applied DNA Sciences Q1 Earnings

February 8, 2024 | markets.businessinsider.com

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results

February 8, 2024 | finance.yahoo.com

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results

February 7, 2024 | benzinga.com

Earnings Preview For Applied DNA Sciences

February 5, 2024 | finance.yahoo.com

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024

February 3, 2024 | investing.com

Applied DNA Sciences Inc (APDN)

February 2, 2024 | finanznachrichten.de

Applied DNA Sciences, Inc.: Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

February 2, 2024 | finance.yahoo.com

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 31, 2024 | finanznachrichten.de

Applied DNA Sciences, Inc.: Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 31, 2024 | msn.com

Applied DNA announces $3.44M registered direct offering

January 31, 2024 | finance.yahoo.com

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

See More Headlines

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Industrial Products
Industry: Testing laboratories
Sub-Industry: N/A
Current Symbol: NASDAQ:APDN
CUSIP: N/A
CIK: 744452
Web: www.adnas.com
Phone: (631) 240-8800
Fax: 631-240-8900
Employees: 52
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.50
High Stock Price Target: $1.50
Low Stock Price Target: $1.50
Potential Upside/Downside: +334.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.54)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,950,000.00
Net Margins: -80.14%
Pretax Margin: -81.25%
Return on Equity: -159.93%
Return on Assets: -71.49%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.77
Quick Ratio: 1.63

Sales & Book Value

Annual Sales: $13.37 million
Price / Sales: 0.44
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.36 per share
Price / Book: 0.96

Miscellaneous

Outstanding Shares: 16,980,000
Free Float: 15,239,000
Market Cap: $5.86 million
Optionable: Optionable
Beta: 0.07

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. James A. Hayward Ph.D. (Age 70)
Sc.D., Chairman, President & CEO
Comp: $468k
Ms. Beth M. Jantzen CPA (Age 48)
Chief Financial Officer
Comp: $300k
Ms. Judith Murrah (Age 66)
COO, Chief Information Officer & Secretary
Comp: $325k
Mr. Clay Shorrock Esq. (Age 39)
J.D., Chief Legal Officer & Executive Director of Business Development
Comp: $300k
Mr. Sanjay M. Hurry
Executive Director of Investor Relations & Corporate Communications
Mr. Tony Benson
Managing Director of EMEA
Mr. Joseph L. Magno
Sales Consultant
Mr. Warren Pearlson
Sales Consultant

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

APDN Stock Analysis - Frequently Asked Questions

Should I buy or sell Applied DNA Sciences stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APDN shares.
View APDN analyst ratings or view top-rated stocks.
What is Applied DNA Sciences' stock price target for 2024?: 1 Wall Street analysts have issued twelve-month price objectives for Applied DNA Sciences' shares. Their APDN share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next year. This suggests a possible upside of 334.8% from the stock's current price.
View analysts price targets for APDN or view top-rated stocks among Wall Street analysts.
How have APDN shares performed in 2024?: Applied DNA Sciences' stock was trading at $0.6168 at the beginning of 2024. Since then, APDN stock has decreased by 44.1% and is now trading at $0.3450.
View the best growth stocks for 2024 here.
When is Applied DNA Sciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our APDN earnings forecast.

How were Applied DNA Sciences' earnings last quarter?: Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its earnings results on Thursday, February, 8th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.31) by $0.22. The technology company had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 159.93% and a negative net margin of 80.14%.
What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?: 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.
What other stocks do shareholders of Applied DNA Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).
How do I buy shares of Applied DNA Sciences?: Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APDN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Applied DNA Sciences Stock (NASDAQ:APDN)

APDN Stock Price History

APDN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

APDN Stock Analysis - Frequently Asked Questions

Overall MarketRank^™